Cheveux Anti-chute
Food supplement declared in France, decision dated 11 November 2026
Cheveux Anti-chute (THERALICA) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- THERALICA
- Food business operator placing the product on the market
- IN'OYA LABORATOIRE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1
- Directions for use
- Prendre 1 gélule par jour
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Femmes allaitantes, Autre : Vitalité, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Hair and nails
Declaration 381970, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Adiantum capillus-veneris L. | Parties aériennes | Extrait sec aqueux | 150 mg |
| Vitis vinifera L. | Pépin | Extrait sec alcoolique | 20 mg |
| Vaccinium myrtillus L. | Fruit | Extrait sec hydroalcoolique | 10 mg |
Substances
| Name | Per day |
|---|---|
| cystéine | 50 mg |
| méthylsulfonate de méthane | 25 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Acide orthosilicique stabilisé par de la choline | Silicium | pas de limite (données insuffisantes) | no fixed dose |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- méthylsulfonate de méthane
Read the warning, when it applies and the studies cited
MSM
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Known adverse reactions
When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- CHEVEUX ANTI-CHUTE Theragreen, declared in 2025 : different composition: 4 ingredient(s) added, 1 missing
- Cheveux Anti-chute Theragreen, declared in 2024 : different composition: 4 ingredient(s) added, 1 missing
- CHEVEUX ANTI CHUTE HOLINUTRIA, declared in 2023 : different composition: 5 ingredient(s) added, 6 missing
Brand : THERALICA
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.